
Clinical Impact of Initiation of U-500 Insulin vs Continuation of U-100 Insulin in Subjects With Diabetes
Author(s) -
Alexander Ramirez
Publication year - 2021
Publication title -
federal practitioner
Language(s) - English
Resource type - Journals
pISSN - 1078-4497
DOI - 10.12788/fp.0105
Subject(s) - medicine , insulin , hypoglycemia , diabetes mellitus , incidence (geometry) , dose , obesity , insulin resistance , endocrinology , physics , optics
The prevalence of obesity and diabetes mellitus (DM) has each increased drastically according to the Centers for Disease Control and Prevention. Growth of severe insulinresistant DM is predicted. U-500 insulin is highly concentrated and can replace less concentrated formulations in patients that need high insulin dosages. The aim of this study was to compare clinical outcomes of U-500 and U-100 insulin regimens in veterans with obesity and insulin resistance.